MedTrace Logo

Illiteracy and Vulnerability to Alzheimer's Disease: Evaluation of Amyloid Pathology by PET Imaging

NCT02494531 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2021-01-13

No results posted yet for this study

Summary

The goal of this study is to improve the diagnosis of Alzheimer's disease (AD) at two different stages (MCI and dementia) in illiterate subjects, using FDG- fluorodeoxyglucose - and florbetapir F 18 -PET imaging. This study will compare amyloid load and cerebral metabolism dysfunction in literate versus illiterate MCI and AD patients.

Conditions

  • Alzheimer Disease

Interventions

RADIATION

Fluorodeoxyglucose-PET

Fluorodeoxyglucose-PET performed within 2 months

RADIATION

florbetapir F 18-PET

florbetapir F 18-PET performed within 2 months

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Catherine Belin, Dr · ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (hospial Avicenne)

  • AMEL OUSLIMANI, PM · Assistance Publique - Hôpitaux de Paris, DRCD

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-12
Primary Completion
2019-05-06
Completion
2020-05-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02494531 on ClinicalTrials.gov